Skip to the page

Data / Form D filings / Kastle BioPartners LP

Kastle BioPartners LP: Form D filing

Kastle BioPartners LP, a company in Boca Raton, FL, filed a Form D with the SEC in 2023. The latest, on January 24, 2023, reports $7.3 million sold of a $30 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1100 HOLLAND DRIVE, Boca Raton, FL, 33487
Phone
(332) 233-7541
Industry
Other
Entity type
Limited Partnership
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1963003

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 24, 2023New notice$30,000,000$7,312,000$22,688,0007Jan 13, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Colby KashExecutive Officer
- Crown BioManagement LLCExecutive Officer
Peter KashExecutive Officer
Jeffrey SerbinExecutive Officer

Other companies in Florida that filed recently

Every Form D from the week of Jan 23, 2023 · All recent filings in Florida · All recent Other filings

Read from SEC EDGAR. Amount sold is what Kastle BioPartners LP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.